Kevin Chuang

Sales Vice President
BONRAYBIO CO., LTD.

Kevin Chuang is the Global Sales VP of Bonraybio Corporation which is now developing, manufacturing and selling their self-branding products related to Male Infertility. With over two decades of international sales experience, Kevin has consistently demonstrated strong capabilities in navigating complex markets, developing effective branding strategies, and establishing robust distributor networks. He has played a crucial role in enhancing the company's market presence and driving revenue growth. Despite the challenges posed by the Covid-19 pandemic, his strategic foresight and leadership have enabled Bonraybio to adapt successfully in a competitive environment. Leveraging his extensive international sales experience and market insights, Kevin has expanded Bonraybio's footprint across 55 countries. His strategic approach ensures Bonraybio's innovative reproductive health products reach global markets efficiently through a well-established distributor network.

Two years of branding business experience in USA during Kevin’s earlier tenure at BenQ Group had trained him understand the pricing and product positioning strategy and how to lead the international sales team for developing the self- branding business through global distributor network. And, these experience and skills had made Kevin successfully lead the international sales team of a start-up medical device company and grow their turnover from USD 0 to USD49M within 8 years which had successfully made the company listed in Taiwan Stock Market.
In conclusion, Kevin Chuang's career reflects his exceptional leadership in global sales and business development within biotechnology. He is skilled in self-branding business, International sales development and strategy, global distributor network establishment and management and graduated with a MBA degree from National Chiao-Tung University, Taiwan.
 

Speech title & Synopsis

Outstanding Company of the Year

"Your health our focus" is the vision and mission of Bonraybio.  Since 2016 until now, we are all based on this philosophy to develop every single product.  As infertility rates are on the rise, most of the focus is on female infertility. However, growing literature points to the male factor in more than 50% of infertility cases.  Therefore, Bonraybio creates "LensHooke" to provide the total solution for male infertility to the customers in more than 53 countries all over the world.  Based on our unique AIOM (Artificial Intelligence Optical Microscopic) technology, we have developed the first fully automatic sperm quality analyzer in the world.  We not only entered the mature ART (Assisted Reproductive Techniques) field, but also opened up the underdeveloped fertility market because it is very easy to use.  In accordance with the strong demand of male infertility solution from the market, the capacity of sales growth is expected.  Bonraybio is moving towards becoming a leading enterprise in the global reproductive health field, dedicated to improving male reproductive health and fostering the continuation of high-quality life.